Your Article Summary
The Choice Between a Therapy-Induced Long-Term Symptom and Shortened Survival Due to Prostate Cancer
European Urology, 08/24/06
Thomas Hopfgarten, et al. - Conclusion: Willingness to accept therapy-induced long-term symptoms to avoid a shortened survival due to prostate cancer varies dramatically among men with localized prostate cancer and a large majority of men are in one of two extreme categories. Among symptoms, long-term fecal leakage was the one fewest men were willing to accept to gain survival
Related Articles
Self-reported symptoms of faecal incontinence among long-term gynaecological cancer survivors and population-based controls
European Journal of Cancer, 11/24/09
Relevance Score: 66%
The short- and long-term effect of duloxetine on painful physical symptoms in patients with generalized anxiety disorder: Results from three clinical trials
Journal of Anxiety Disorders, 11/13/09
Relevance Score: 65%
Health-related quality of life in long-term survivors of testicular cancer
Journal of Clinical Oncology, 11/02/09
Relevance Score: 65%
Long-term efalizumab therapy for patients with moderate-to-severe, chronic plaque psoriasis
International Journal of Dermatology, 11/25/09
Relevance Score: 64%
Long-term posttraumatic effects of intraoperative awareness in children
Paediatric Anaesthesia, 11/20/09
Relevance Score: 64%
Today in Renal/Urologic...keeping you current
Receive free subspecialty "5-minute updates" via email
Evidence for distinct alterations in the FGF axis in prostate cancer progression to an aggressive clinical phenotype
The Journal of Pathology, 12/11/09
Comorbidity, body mass index, and age and the risk of nonprostate-cancer-specific mortality after a postradiation prostate-specific antigen recurrence
Cancer, 12/11/09
Suppression of Hypoxia-Inducible Factor 2alpha Restores p53 Activity via Hdm2 and Reverses Chemoresistance of Renal Carcinoma Cells
Cancer Research, 12/11/09

See Latest Articles